|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name |
|
Date of
incorporation
or
acquisition |
|
Place of
incorporation
(or
establishment)
/operation |
|
Percentage of
ownership
as of
December
31, 2025 |
|
|
Percentage of
ownership
as of
December
31, 2024 |
|
|
Principal activities |
|
Sinovac Biotech (Hong Kong) Limited
("Sinovac Hong Kong") |
|
October 2008 |
|
Hong Kong SAR, China |
|
|
100.00 |
% |
|
|
100.00 |
% |
|
International sales
and marketing |
|
Sinovac Biotech Co., Ltd.
("Sinovac Beijing") |
|
April 2001 |
|
People's
Republic of
China ("PRC") |
|
|
73.09 |
% |
|
|
73.09 |
% |
|
Research and development,
production and sales of
vaccine products |
|
Sinovac Life Sciences Co., Ltd.
("Sinovac LS")
(formerly Sinovac Research &
Development Co., Ltd.) |
|
May 2009 |
|
PRC |
|
|
59.24 |
% |
|
|
59.24 |
% |
|
Research and development,
production and sales of
vaccine products |
|
Sinovac (Dalian) Vaccine
Technology Co., Ltd.
("Sinovac Dalian") |
|
January 2010 |
|
PRC |
|
|
68.00 |
% |
|
|
68.00 |
% |
|
Research and development,
production and sales of
vaccine products |
|
Sinovac Biomed Co., Ltd.
("Sinovac Biomed") |
|
April 2015 |
|
PRC |
|
|
100.00 |
% |
|
|
100.00 |
% |
|
Distribution of
vaccine products |
|
Sinovac Holding Group Co., Ltd.
("Sinovac Beijing Holding") |
|
June 2024 |
|
PRC |
|
|
100.00 |
% |
|
|
100.00 |
% |
|
Regional holding company |
|
Sinovac Business Services
(Dalian) Co., Ltd. |
|
January 2024 |
|
PRC |
|
|
100.00 |
% |
|
|
100.00 |
% |
|
Shared Service Center |
|
Sinovac Biotech (Singapore) Pte. Ltd.
("Sinovac Singapore") |
|
August 2020 |
|
Singapore |
|
|
100.00 |
% |
|
|
100.00 |
% |
|
International sales
and marketing |
|
Sinovac (Chengdu) Biotech Co., Ltd.
("Sinovac Chengdu") |
|
September 2024 |
|
PRC |
|
|
100.00 |
% |
|
|
100.00 |
% |
|
Research and development,
production and sales of
vaccine products |